At a time when much about COVID-19 remained a mystery, U.K.-based PrecisionLife used AI and combinatorial analytics to discover new genes associated with severe symptoms and hospitalizations for patients. The techbio company’s study, published in June 2020, pinpoints 68 novel genes associated with individuals who experienced severe disease from the virus. Over 70 percent of Read article >
The post AI for Personalized Health: Startup Advances Precision Medicine for COVID-19, Chronic Diseases appeared first on NVIDIA Blog.